510(k) device
Anterion
Heidelberg Engineering GmbH · Tomography, Optical Coherence (OBO, Class II) · First FDA decision Nov 5, 2021, newest Sep 11, 2026GlaucomaMacular degeneration and retinal disease
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
510(k) pathway
Device trials
14
Naming "Anterion"
MAUDE reports
0
Brand "Anterion", since 2015
PubMed studies
171
Mentioning "Anterion"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Anterion
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
- ANTERION510(k)
K261019 · Decided Sep 11, 2026 · 168 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
- Anterion510(k)
K240924 · Decided Dec 13, 2024 · 253 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
- Anterion510(k)
K230897 · Decided Oct 11, 2023 · 194 days after receipt
Device type: Tomography, Optical Coherence (OBO) · Ophthalmology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Anterion", any status and sponsor, newest update first.
- Heidelberg Engineering ANTERION Software Comparison StudyActive, not recruiting
Heidelberg Engineering GmbHNot on our public-company list
NCT06657716 · 60 participants (planned) · Start Oct 2, 2024 · Primary completion Dec 2026
Device: ANTERION investigational · For: Eyes With Normal Anterior Segment; Eyes With Abnormal Anterior Segment
Sites: Wilmar, Minnesota
- UNITY DX Cornea StudyRecruiting
Alcon ResearchNot on our public-company list
NCT07768735 · 110 participants (planned) · Start Sep 24, 2026 · Primary completion Dec 2026
Device: UNITY DX; ANTERION · For: Tomography
Sites: Salt Lake City, Utah
- Measuring Corneal ParametersCompleted
Icare Finland OyNot on our public-company list
NCT07629232 · 50 participants · Start Jun 1, 2026 · Primary completion Sep 30, 2026
Device: Investigational device; Comparator device · For: Corneal Parameters
Sites: Bonn, Germany
11 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Anterion", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code OBO
13 reports: 4 malfunction, 9 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Anterion"[tiab]. The summary above synthesizes these.
- Iridociliary measurements using the Anterion swept-source optical coherence tomography.
Patyal S, Yadav AK, Anthony H, et al. · Indian J Ophthalmol · 2023
- Heidelberg Anterion Swept-Source OCT Corneal Epithelial Thickness Mapping: Repeatability and Agreement With Optovue Avanti.
Feng Y, Reinstein DZ, Nitter T, et al. · J Refract Surg · 2022
- Comparison of ocular biometry and refractive outcome between ANTERION and IOL Master 700.
Panda A, Nanda A, Sahoo K · Indian J Ophthalmol · 2022
- Erratum for "Heidelberg Anterion Swept-Source OCT Corneal Epithelial Thickness Mapping: Repeatability and Agreement with Optovue Avanti".
J Refract Surg · 2024Published Erratum
- Novel High-Resolution Imaging Using ANTERION Optical Coherence Tomography to Assess Fluid Reservoir Change in Scleral Lens Periphery.
Tran S, Roberts CJ, Mahmoud A, et al. · Eye Contact Lens · 2022
- Comparison of Anterion, MS-39, Pentacam, and Sirius in Corneal Assessment Prior to Refractive Surgery.
Anwar M, Bühren J, Kook D, et al. · Clin Ophthalmol · 2025
- Agreement between 2 SS-OCT biometry devices.
McLintock C, Niyazmand H, Seo S, et al. · J Cataract Refract Surg · 2022
- Comparison of Refractive Prediction Accuracy With Three Optical Devices.
Cheng SM, Li X, Zhang JS, et al. · J Refract Surg · 2023
- Exploring anterion capsular contraction syndrome in cataract surgery: insights into pathogenesis, clinical course, influencing factors, and intervention approaches.
Lin X, Ma D, Yang J · Front Med (Lausanne) · 2024Review
- Comparison of 2 modern swept-source optical biometers-IOLMaster 700 and Anterion.
Langenbucher A, Szentmáry N, Cayless A, et al. · Graefes Arch Clin Exp Ophthalmol · 2023
- Agreement between Two Swept-Source Optical Coherence Tomography Biometers and a Partial Coherence Interferometer.
Moon JY, Cho SC, Kim HJ, et al. · Korean J Ophthalmol · 2022Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code OBO.
- SPECTRALIS HRA+OCT and variantsHeidelberg Engineering GmbH · 510(k) 2026
- CIRRUS HD-OCT Model 6000Carl Zeiss Meditec, Inc. · 510(k) 2024
- Spectralis HRA + OCT and variantsHeidelberg Engineering GmbH · 510(k) 2018
- 3D OPTICAL COHERENCE TOMOGRAPHY 3D OCT-1 (type: Maestro2)Topcon Corporation · 510(k) 2024
- Tomey Cornea/Anterior Segment OCT (CASIA2)Tomey Corporation · 510(k) 2025
- P200TE (A10700)Optos Plc. · 510(k) 2024
- RESCAN 700, CALLISTO eyeCarl Zeiss Meditec, AG · 510(k) 2019
- iVueOptovue, Inc. · 510(k) 2017
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.